R1 Wins ‘Best in KLAS’ Across Multiple RCM Categories for 2025Customers Say R1’s Focus on Delivering Innovation & Expertise is Solving Healthcare Challenges
TowerBrook and CD&R Complete Acquisition of R1 RCMR1 RCM Becomes Privately Held Company; Joe Flanagan Reappointed as CEO
R1 RCM Forms Special Committee to Evaluate Strategic AlternativesMURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (
NASDAQRCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation of a special committee comprised solely of independent directors (the “Special Committee”) to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the Securities and Exchange Commission on February 26, 2024. The Company issued the following statement:
R1 RCM Issues 2022 Environmental, Social, and Governance ReportReport details company’s continued commitment to corporate responsibility and sustainability on behalf of its customers and their patients, employees, communities, and shareholders
R1 RCM & Cloudmed Ranked #1 by KLAS in Multiple Categories for 2023Top rankings in Ambulatory RCM Services, Robotic Process Automation and Denials Management Services underscore expertise and ability to deliver complete range of flexible healthcare revenue cycle solutions
